A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression

PURPOSE: We explored the clinical utility of human epidermal growth factor receptor-2 extracellular domain (HER2/ECD) in patients treated for an invasive breast cancer with HER2 overexpression. METHODS: We prospectively studied HER2/ECD levels in the sera of 334 women included between 2007 and 2014,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Breast Cancer Res Treat
Autores principales: Reix, Nathalie, Malina, Charlotte, Chenard, Marie-Pierre, Bellocq, Jean-Pierre, Delpous, Stéphanie, Molière, Sébastien, Sevrin, Anthony, Neuberger, Karl, Tomasetto, Catherine, Mathelin, Carole
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer US 2016
Materias:
Preclinical Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5065601/
https://ncbi.nlm.nih.gov/pubmed/27709352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-4000-z
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares